-
1
المؤلفون: M Schuur, Mathilde C.M. Kouwenhoven, L de Glopper, F E L van den Elzen, M. E. van Linde, M Sintemaartensdijk, A N van der Vegt, N Grun, Tjeerd J. Postma, J Osinga
المصدر: Neuro Oncol
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Temozolomide, business.industry, medicine.medical_treatment, Lomustine, medicine.disease, Chemotherapy regimen, First line treatment, Radiation therapy, Second line, Internal medicine, medicine, Oral Presentations, Neurology (clinical), business, medicine.drug, Glioblastoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26585b03551878dc0e5caee325af119
https://europepmc.org/articles/PMC8427454/ -
2
المؤلفون: M Schuur, Joost J.C. Verhoeff, J.F. de Haan, Mathilde C.M. Kouwenhoven, Tjeerd J. Postma, C A den Otter, P. C. de Witt Hamer, N Grun, Birgit I. Lissenberg-Witte, M Sintemaartensdijk, F.Y.F.L. De Vos, F E L van den Elzen, Anna M.E. Bruynzeel, J Osinga, A N van der Vegt, Joost L M Jongen, M. E. van Linde
المصدر: Neuro Oncol
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Temozolomide, business.industry, Treatment outcome, Time to treatment, medicine.disease, Poster Presentations, Hematological toxicity, Tumor progression, Internal medicine, Cost of illness, Medicine, Identification (biology), Neurology (clinical), business, Glioblastoma, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a04ea00f193eaaabae4b5d52c64bdda
https://doi.org/10.1093/neuonc/noab180.138